메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT

[ 메디채널 김갑성 기자 ] Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient The ACTION3 Phase 3 trial explores the efficacy and safety of DMX-200 in FSGS patients when dosed in combination with standard-of-care blood pressure medication over 2 years Of the 286 adult patients dosed in the trial, 69 have already completed the full 2-year treatment period and of those, 65 entered voluntarily into the Open Label Extension (OLE) study, representing 94% OLE uptake The study has now successfully passed seven sc
- 김갑성 기자
- 2025-12-15 15:02
ORGE Co., Ltd. Enters Japan's Organic Health Food Market, Strengthening Strategy to Capture Local Wellness Trends

SEOUL, South Korea, Dec. 15, 2025 -- ORGE Co., Ltd., a Korean brand specializing in organic health foods, is accelerating its push into the Japanese market, marking a new phase in its global expansion. In November, ORGE participated in the Japan Food Tech Fair held at Tokyo Big Sight, where it engaged in partnership discussions with major Japanese distributors and health food buyers. Building on these talks, the company has announced plans for an official launch in Japan in the first half of next year. ORGE's flagship lineup of organic, low-sodium health-focused samgyetang (Korean gins
- 노기식 기자
- 2025-12-15 14:35
Brandstars "2025 Korean wave luxury brands" Announcement

SEOUL, South Korea, Dec. 15, 2025 -- The Brand Stars Selection Committee announced the final selection results of the "2025 Korean wave luxury brands" Marking its eighth anniversary this year, the event, which will be presented together by major media in China and Asia, is aimed at selecting and presenting representative Korean wave luxury brand to overseas consumers who love K-wave and providing correct information to help consumers make choices. The final industrial brands selected are Samsung Electronics' Galaxy Z Fold 7 Z Flip 7, 'Bespoke Ai' 'Hyundai Genesis, Ioni
- 김장윤(JASON KIM) 기자
- 2025-12-15 14:22
LifeWave Highlights Five Key Focus Areas at Taiwan-Hong Kong-Macau Annual Conference, Featuring a Boundary-Breaking Indoor Drone Opening

TAIPEI, Dec. 15, 2025 -- LifeWave hosted the SHARE THE LIGHT Taiwan–Hong Kong–Macau Annual Recognition Conference on December 14 at the Taipei International Convention Center, bringing together nearly 2,000 Brand Partners and guests. The event marked a milestone, reflecting LifeWave's 17 years of growth and market development in Taiwan. The conference opened with an innovative drone light performance that brought large-scale drone formations—traditionally seen outdoors—onto an indoor stage. Through cross-venue technology integration, the performance demonstrated new possibiliti
- 노기식 기자
- 2025-12-15 14:12
Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

STOCKHOLM, Dec. 15, 2025 -- Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which was invested in and incubated by Viva Biotech Holdings. Under the terms of the agreement, Sobi will pay up to US$1.5 billion in total transaction value, including an upfront payment at closing of US$950 million, subject to customary adjustments, and contingent consideration of up to US$550 million. The transaction is expected to close in the first half of 2026. Viva Biotech expects that the
- 김갑성 기자
- 2025-12-15 14:06
Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice

HONG KONG, Dec. 15, 2025 -- Manulife (International) Limited ("Manulife") and Bupa International Limited ("Bupa") are pleased to announce today the signing of a Memorandum of Understanding ("MoU"), intended to establish a strategic collaboration in Hong Kong that will provide customers with greater convenience and flexibility in managing their health. United by a shared commitment to enhancing healthcare and wellbeing for the people of Hong Kong, this proposed strategic collaboration will combine the strengths of two industry leaders to build a more robust
- 황정호 기자
- 2025-12-15 13:45
Vantage Concludes a Landmark APAC Gala Dinner in Vietnam, Celebrating Regional Excellence and a Bold Vision for 2026

PORT VILA, Vanuatu, Dec. 15, 2025 -- Vantage proudly concluded its APAC Gala Dinner 2025, marking a milestone moment as the signature annual celebration was hosted in Vietnam for the first time. The event gathered hundreds of distinguished partners, IBs, VIP clients, and industry leaders from across the region, delivering an unforgettable evening that showcased Vantage's ambition, innovation, and accelerating momentum in Asia-Pacific. The gala opened with an elegant welcome journey, where guests were greeted by immersive light installations and a premium networking expe
- 황정호 기자
- 2025-12-15 13:41
Xinhua Silk Road: Conference held in E. China biz hub to highlight burgeoning regional M&As

BEIJING, Dec. 15, 2025 -- When gaining speed in building a global merger and acquisition (M&A) highland, east China's business hub Shanghai recently witnessed a grand gathering of M&A industry players. The 2025 Mergers and Acquisitions Finance Conference, which came right at the first anniversary for the release of Shanghai's 3-year action plan to support M&A of listed firms, shed light on improvements in both quality and quantity of local M&As. As the China M&A Composite Index (2025) debuted during the conference showed, Shanghai and other areas in t
- 황정호 기자
- 2025-12-15 12:46
Everest Medicines Announces 2030 Strategy and Increase in Shareholdings by Directors and Substantial Shareholder

SHANGHAI, Dec. 15, 2025 -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the launch of its 2030 Strategy, outlining a comprehensive five-year roadmap to drive sustainable growth. Under this strategy, the Company aims to further deepen its product pipeline, maximize the value of its commercial platform, and advance the globalization of its research and development ("R&D") and commercializa
- 김갑성 기자
- 2025-12-15 12:40
Hero Esports Transforms Beijing's National Stadium into Record-Breaking Mobile Esports Tournament

62,196 fans attended the 10th annual King Pro League ("KPL") Grand Finals, the largest attendance at a single esports event Hosted by Tencent and organized by Hero Esports, the Honor of Kings tournament drew crowds from both China and overseas including, but not limited to, Thailand and Australia China is home to an esports user base of over 495 million[1] SHANGHAI, Dec. 15, 2025 -- As the year draws to a close, Hero Esports celebrates the record-breaking success of the KPL 2025 Grand Finals, hosted by Tencent and organized by Hero Esports. 62,196 fans attended the 10th
- 김장윤(JASON KIM) 기자
- 2025-12-15 11:27

이전

61 62 63 64 65 66 67 68 69 70

많이 본 기사

최근기사

2026-01-12_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 12일 13시 40분